Click on image to view larger version.

Figure 1 Individual and Pooled Risks of Adverse Outcomes

Forest plots showing individual and pooled risks of death (A), death, and nonfatal recurrent myocardial infarction (B), death, nonfatal recurrent myocardial infarction, or rehospitalization for angina/heart failure (C), and nonfatal recurrent myocardial infarction (D) comparing late percutaneous coronary intervention (PCI) versus best medical therapy (Rx) only for infarct-related artery occlusion late (>12 h) in the course of acute myocardial infarction. ALKK = Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte; BRAVE-2 = Beyond 12 Hours Reperfusion Alternative Evaluation Trial; CI = confidence interval; DEPOCI = Randomized Trial of Occluded Artery Angioplasty After Acute Myocardial Infarction; OAT = Occluded Artery Trial; OR = odds ratio; SWISSI II = Swiss Interventional Study on Silent Ischemia Type II; TOAT = The Occluded Artery Trial; TOMIIS = Total Occlusion Post-Myocardial Infarction Intervention Study; TOPS = Treatment of Post-thrombolytic Stenoses.